GlassScriptPhysician profile
Ian S Sink
NPI 1588820609
$4,319.08
in general payments reported to CMS, 2019-2025
32 companies · $608 in 2025
The $608 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $252 · 2021: $667 · 2022: $460 · 2023: $204 · 2024: $1,926 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,775 · Travel and Lodging: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,775.15 |
| Travel and Lodging | $963.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,154.98 | 2024 | |
| Aspira Women'S Health INC | $349.54 | 2022-2024 | Ova1 |
| Biogen, INC. | $334.04 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $329.60 | 2021 | |
| Abbvie INC. | $328.25 | 2020-2022 | |
| Pfizer INC. | $227.70 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $189.11 | 2023-2025 | Myfembree |
| Organon LLC | $171.87 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $167.66 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $92.24 | 2022 | |
| Ethicon US, LLC | $89.53 | 2019-2024 | Enseal X1 |
| Gynesonics, INC. | $79.71 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $74.29 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.68 | 2019-2022 | |
| Shield Therapeutics INC | $67.13 | 2023-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $65.52 | 2019-2022 | |
| Myovant Sciences INC. | $54.52 | 2021-2022 | |
| Avanos Medical | $54.32 | 2019-2023 | On-Q* Pump and Accessories |
| Astellas Pharma US INC | $52.53 | 2024-2025 | Veozah |
| Sage Therapeutics, LLC | $49.48 | 2020-2022 | |
| Amgen INC. | $49.05 | 2021-2025 | Prolia, Evenity |
| Baxter Healthcare | $48.16 | 2024-2025 | Perclot |
| Millicent US INC | $39.26 | 2023 | Femring, Intrarosa |
| Medtronic, INC. | $30.44 | 2024 | Truclear |
| Innovation Technologies INC | $24.99 | 2025 | Irrisept |
| Exact Sciences Corporation | $22.33 | 2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $21.94 | 2020 | |
| Roche Diagnostics Corporation | $19.92 | 2019 | |
| Horizon Therapeutics Plc | $19.70 | 2020 | |
| Agile Therapeutics, INC. | $14.48 | 2021 | |
| Lupin INC. | $14.21 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.90 | 2025 | Iovera, Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Sink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.